the FSL rat model of depression;
decreased appetite;
elevated REM sleep;
neurotransmitter changes;
forced swim test;
tricyclics;
SSRIs;
novel antidepressants;
D O I:
10.1016/j.neubiorev.2005.03.015
中图分类号:
B84 [心理学];
C [社会科学总论];
Q98 [人类学];
学科分类号:
03 ;
0303 ;
030303 ;
04 ;
0402 ;
摘要:
The Flinders Sensitive Line (FSL) rats were originally selectively bred for increased responses to an anti cholinesterase agent. The FSL rat partially resembles depressed individuals because it exhibits reduced appetite and psychomotor function but exhibits normal hedonic responses and cognitive function. The FSL rat also exhibits sleep and immune abnormalities that are observed in depressed individuals. Neurochemical and/or pharmacological evidence suggests that the FSL rat exhibits changes consistent with the cholinergic, serotonergic, dopaminergic, NPY, and circadian rhythm models but not the noradrenergic, HPA axis or GABAergic models of depression. However, evidence for the genetic basis of these changes is lacking and it remains to be determined which, if any, of the neurochemical changes are primary to the behavioral alterations. The FSL rat model has been very useful as a screen for antidepressants because known antidepressants reduced swim test immobility when given chronically and psychomotor stimulants did not. Furthermore, rolipram and a melatonin agonist were shown to have anti-immobility effects in the FSL rats and later to have antidepressant effects in humans. Thus, the FSL rat model of depression exhibits some behavioral, neurochemical, and pharmacological features that have been reported in depressed individuals and has been very effective in detecting antidepressants. (c) 2005 Elsevier Ltd. All rights reserved.
机构:Karolinska Inst, Dept Physiol & Pharmacol, Div Pharmacol, S-17177 Stockholm, Sweden
Angelucci, F
Aloe, L
论文数: 0引用数: 0
h-index: 0
机构:Karolinska Inst, Dept Physiol & Pharmacol, Div Pharmacol, S-17177 Stockholm, Sweden
Aloe, L
Jiménez-Vasquez, P
论文数: 0引用数: 0
h-index: 0
机构:Karolinska Inst, Dept Physiol & Pharmacol, Div Pharmacol, S-17177 Stockholm, Sweden
Jiménez-Vasquez, P
Mathé, AA
论文数: 0引用数: 0
h-index: 0
机构:
Karolinska Inst, Dept Physiol & Pharmacol, Div Pharmacol, S-17177 Stockholm, SwedenKarolinska Inst, Dept Physiol & Pharmacol, Div Pharmacol, S-17177 Stockholm, Sweden
机构:Karolinska Inst, Dept Physiol & Pharmacol, Div Pharmacol, Stockholm, Sweden
Angelucci, F
Aloe, L
论文数: 0引用数: 0
h-index: 0
机构:Karolinska Inst, Dept Physiol & Pharmacol, Div Pharmacol, Stockholm, Sweden
Aloe, L
Jiménez-Vasquez, P
论文数: 0引用数: 0
h-index: 0
机构:Karolinska Inst, Dept Physiol & Pharmacol, Div Pharmacol, Stockholm, Sweden
Jiménez-Vasquez, P
Mathé, AA
论文数: 0引用数: 0
h-index: 0
机构:
Karolinska Inst, Dept Physiol & Pharmacol, Div Pharmacol, Stockholm, SwedenKarolinska Inst, Dept Physiol & Pharmacol, Div Pharmacol, Stockholm, Sweden
机构:Karolinska Inst, Dept Physiol & Pharmacol, Div Pharmacol, S-17177 Stockholm, Sweden
Angelucci, F
Aloe, L
论文数: 0引用数: 0
h-index: 0
机构:Karolinska Inst, Dept Physiol & Pharmacol, Div Pharmacol, S-17177 Stockholm, Sweden
Aloe, L
Jiménez-Vasquez, P
论文数: 0引用数: 0
h-index: 0
机构:Karolinska Inst, Dept Physiol & Pharmacol, Div Pharmacol, S-17177 Stockholm, Sweden
Jiménez-Vasquez, P
Mathé, AA
论文数: 0引用数: 0
h-index: 0
机构:
Karolinska Inst, Dept Physiol & Pharmacol, Div Pharmacol, S-17177 Stockholm, SwedenKarolinska Inst, Dept Physiol & Pharmacol, Div Pharmacol, S-17177 Stockholm, Sweden
机构:Karolinska Inst, Dept Physiol & Pharmacol, Div Pharmacol, Stockholm, Sweden
Angelucci, F
Aloe, L
论文数: 0引用数: 0
h-index: 0
机构:Karolinska Inst, Dept Physiol & Pharmacol, Div Pharmacol, Stockholm, Sweden
Aloe, L
Jiménez-Vasquez, P
论文数: 0引用数: 0
h-index: 0
机构:Karolinska Inst, Dept Physiol & Pharmacol, Div Pharmacol, Stockholm, Sweden
Jiménez-Vasquez, P
Mathé, AA
论文数: 0引用数: 0
h-index: 0
机构:
Karolinska Inst, Dept Physiol & Pharmacol, Div Pharmacol, Stockholm, SwedenKarolinska Inst, Dept Physiol & Pharmacol, Div Pharmacol, Stockholm, Sweden